Caricamento...
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple Myeloma
SIMPLE SUMMARY: In the last decade, proteasome inhibitors (PIs) have become a standard for the treatment of multiple myeloma (MM). As a consequence of the pleiotropic effects of PIs on various signaling pathways, synergistic or additive activities with other anti-myeloma therapies have been identifi...
Salvato in:
| Pubblicato in: | Cancers (Basel) |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8000754/ https://ncbi.nlm.nih.gov/pubmed/33799793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13061235 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|